NASDAQ NMS - GLOBAL MARKET · EVGN
+5.51% · +$0.0309 · Vol 1.0M
Market closed · last close 4:00 PM ET · price as of 19:45:59 ET
Evogene Ltd

Evogene Ltd

Biotechnology
$0.5914
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Valuation absence reason unknown · Sentiment absence reason unknown
EVGN
Evogene Ltd
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

32/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EVGN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EVGN catalysts
About Evogene Ltd
Biotechnology
Listed since
2008
Employees
52
Country
IL

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.5437
Day high
$0.5800
Day low
$0.5412
Previous close
$0.5605
52W high
$1.46
-59.49% from high
52W low
$0.3889
19% of range
Market cap
$8.9M
EPS
$-1.3841
Beta
1.74
Shares out
15.8M
Volume
1M
1.88× rel vol
Avg volume
553.6K
VWAP
$0.5814
Price history computed in-house
1W
+5.61%
1M
+9.01%
3M
-16.59%
1Y
-54.68%
YTD
-46.24%
SMA 50 $0.5343 · above
SMA 200 $0.8246 · below
52W position 19%

EVGN overview

Veridion Score
32
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EVGN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EVGN Form 4 filings
Public disclosures

Congress activity in EVGN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for EVGN in the cached public ledger.

Federal contracts

EVGN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EVGN in this window.
Lobbying spend

EVGN lobbying filings, year to date.

Registered lobbying filings matched to Evogene Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EVGN in this window.
Loading news for EVGN
Analyst ratings
Sovereign unlock shows live analyst consensus for EVGN.
Options
Sovereign unlock shows live options positioning for EVGN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.